For context on SAMe and related evidence limits, see the NIH NCCIH resource S-Adenosyl-L-Methionine (SAMe): In Depth
It says it will remove products from the market if they claim to treat or change how the body works if they are not licensed under the Human Medicines Regulations Act 2012, and that it strongly advises against purchasing and using unauthorised medicinal products - "particularly those promoted on social media"
Results: Compared to the absence of calcifications, spotty calcifications were associated with male gender (OR 3.72, 95% confidence interval [CI] 1.0613.05), while large calcifications with older patients (OR 1.60 per 5 years of age, 95% CI 1.202.13)
Standard protocols follow 5-days-on/2-days-off Tesamorelin Targets Visceral Fat Metabolism Tesamorelin is a growth hormone-releasing hormone analog that targets visceral fat metabolism by restoring growth hormone signaling
[DOI] [PubMed] [Google Scholar] 11.Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D, Vrcic H, Sebecic B
At Lighthouse Foot and Ankle, Im committed to exploring and integrating evidence-based innovations into patient care
